En enero de 2023 el fármaco recibió la autorización del organismo regulador americano de alimentos y medicamentos, la Food and Drug Administration (FDA), por la vía de aprobación acelerada y, a p...
Read more
Oryzon Genomics announced today the receipt of the official meeting minutes from a recent End-of-Phase II meeting for vafidemstat in Borderline Personality Disorder (BPD) with the US Food and Drug Adm...
Read more
El estudio ha investigado la eficacia del axatilimab, un nuevo anticuerpo monoclonal humanizado que actúa inhibiendo el receptor CSFR1, presente en macrófagos y monocitos, células implicadas en el ...
Read more
Hallan pruebas suficientes de un fármaco utilizado para tratar el cáncer de médula ósea y el sarcoma de Kaposi que es seguro y eficaz en el tratamiento de la telangiectasia hemorrágica hereditari...
Read more
CNIO researchers have discovered that cancer perverts certain brain cells, the astrocytes, and causes them to produce a protein that works in favour of the tumour. A drug, silibinin, inhibits this pro...
Read more
Demuestran por primera vez los beneficios de una estrategia basada en añadir el fármaco de inmunoterapia durvalumab a la quimioterapia neoadyuvante que se administra antes de la cirugía para extirp...
Read more
Highlight the main technical, clinical, and regulatory challenges currently faced when integrating these biomarkers into daily clinical practice and adapting them to different healthcare settings. The...
Read more
This analysis explores biological factors that could influence how patients with metastatic colorectal cancer with BRAF V600E mutation respond or develop resistance to targeted therapy.
Read more
EL PRS® CK-Storm será el primero de una serie de medicamentos, basados en el uso de secretomas dirigidos, para ayudarán a combatir diferentes tipos de patologías autoinmunes.
Read more
The Phase I/II ADCElerate-01 trial is designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of ADCE-D01 as a monotherapy in patients with metastatic and/or unresectable STS
Read more
A Cochrane review led by ISGlobal researchers updates the evidence on interventions for malaria and HIV during pregnancy
Read more
David Segarra: “ApToll is an immune modulator to treat ischaemic stroke in the acute phase. We have successfully completed Phase 2a and will soon conduct Phase 2b. We are also testing ApToll for oth...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
